You are here: Industry Insights > FDA

News List

FDA grants priority review to Boehringer-Lilly’s Jardiance for heart failure Pharmaceutical-Technology
November 15, 2021
Boehringer Ingelheim Pharmaceuticals and Eli Lilly have obtained the US Food and Drug Administration (FDA) priority review for Jardiance (empagliflozin) to potentially treat heart failure...
Pfizer Asks FDA to Approve Booster Shots for All U.S. Adults Drugs
November 11, 2021
As concerns mount that holiday travel and indoor gatherings will foster the spread of COVID-19, Pfizer on Tuesday asked the U.S. Food and Drug Administration to approve booster shots...
INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S. prnewswire
November 10, 2021
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat cancer...
Electronic Drug Registration and Listing Instructions FDA
November 10, 2021
There are three steps, or submissions, that are needed to register an establishment and list a drug with FDA. Each of these steps requires an initial submission followed by periodic updates...
FDA declines to grant EUA for NRx’s Zyesami to treat Covid-19 patients Pharmaceutical-Technology
November 08, 2021
The US Food and Drug Administration (FDA) has declined to grant an emergency use authorization (EUA) for NRx Pharmaceuticals’ therapy, Zyesami (aviptadil), to treat critical Covid-19 patients who have respiratory failure.
US authorises more batches of J&J COVID-19 vaccine made at Emergent ExpressPharma
November 08, 2021
The US Food and Drug Administration (FDA) said it had authorised the use of two more batches of Johnson & Johnson’s one-dose COVID-19 vaccine manufactured at the problem-plagued Baltimore...
FDA provides EUA for Pfizer-BioNTech’s Covid-19 vaccine in children Pharmaceutical-Business-Review
November 05, 2021
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Pfizer-BioNTech’s Covid-19 vaccine for children aged 5 to 11 years.
FDA authorises Comirnaty® for emergency use in five to 11 year olds EuropeanPharmaceuticalReview
November 02, 2021
The US Food and Drug Administration (FDA) authorised the emergency use of the COVID-19 Vaccine Comirnaty® for the prevention of COVID-19 to include children five through 11 years of age.
Novatek seeks FDA authorisation for oral drug to treat Covid-19 Pharmaceutical-Technology
November 02, 2021
Novatek Pharmaceuticals has sought emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its oral TQ Formula to treat Covid-19-infected individuals in the outpatient setting.
FDA Delays Decision on Moderna COVID-19 Vaccine for Younger Teens Drugs
November 02, 2021
The U.S. Food and Drug Administration has delayed a decision on whether to approve emergency use of the Moderna COVID-19 vaccine in 12- to 17-year-olds until at least January, the company announced Sunday.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 365 366 Next page